Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Abbott Laboratories (ABT) shares rose 2.19% to $116.64 on a positive trading day, outperforming the broader market's gains. The S&P 500 and Dow Jones also closed higher. Abbott remains 15.16% below its 52-week high of $137.49. While competitors like Johnson & Johnson, Pfizer, and Merck saw modest gains, Abbott's performance was mixed relative to peers. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories (ABT) rose 2.19% to $116.64 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.43% to 7,674.37 and the Dow Jones Industrial Average rising 0.98% to 53,277.01.
Abbott Laboratories closed 15.16% short of its 52-week high of $137.49, which the company reached on September 22nd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) rose 1.07% to $270.24, Pfizer Inc. (PFE) rose 1.01% to $28.07, and Merck & Co. Inc. (MRK) rose 2.39% to $152.55.
Trading volume (9.8 M) remained 2.1 million below its 50-day average volume of 11.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-21-26 1634ET